+61 3 9467 4966
enquiries@cyclotek.com
Menu
Home
Company
About Us
Research Philosophy
Corporate
Time Line History
Brochures
Products
Compounded Products
Product Supply
Contract Manufacturing
Quality System
Logistics
Collaborations
News
Facilities
Corporate
Melbourne – Bundoora
Brisbane – Woolloongabba
Wellington – New Zealand
Melbourne – Parkville
Sydney – Lucas Heights
Sydney – Macquarie University Hospital
News
Categories
Categories
Select Category
Clinical
Company
Latest News
Research
Uncategorized
National University of Singapore (NUS) Yong Loo Lin School of Medicine – Clinical Imaging Research Centre (CIRC) and Cyclotek Announce Strategic Collaboration to Strengthen Radiopharmaceutical Capability in Singapore and Across ASEAN
Posted on: 04 March 2026
Clinical
,
Company
,
Latest News
read More
CYCLOTEK’S NEW CEO SIGNALS EXPANSION INTO WESTERN AUSTRALIA
Posted on: 13 November 2025
Company
,
Latest News
read More
Cyclotek and Duchembio announce APAC extension of the license agreement for [18F]FP-CIT for the diagnosis of neurodegenerative disorders
Posted on: 25 September 2025
Clinical
,
Company
,
Latest News
read More
Cyclotek Awarded CRC-P Round 16 Grant to Advance Nanobody-Based Theranostic Platform for Cancer
Posted on: 03 September 2025
Clinical
,
Company
,
Latest News
,
Research
read More
Cyclotek Enables First in Human Company-Sponsored Trial with Terbium-161 Radiopharmaceutical in Australia
Posted on: 03 July 2025
Clinical
,
Latest News
,
Research
read More
Cyclotek Expands Radiopharmaceutical Capacity in Queensland: A New Era for Imaging and Therapy Providers
Posted on: 27 February 2025
Company
,
Latest News
read More
Page 1 of 4
1
2
3
4
Next
© 2026 Cyclotek. All rights reserved
[contact-form-7 id=”714″ title=”Update Form”]
